Lee Financial’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-260
| Closed | -$18.6K | – | 855 |
|
|
2023
Q4 | $18.6K | Hold |
260
| – | – | ﹤0.01% | 330 |
|
|
2023
Q3 | $13.5K | Hold |
260
| – | – | ﹤0.01% | 361 |
|
|
2023
Q2 | $16.5K | Hold |
260
| – | – | ﹤0.01% | 333 |
|
|
2023
Q1 | $14.1K | Buy |
260
+40
| +18% | +$2.17K | ﹤0.01% | 364 |
|
|
2022
Q4 | $11.6K | Hold |
220
| – | – | ﹤0.01% | 434 |
|
|
2022
Q3 | $10K | Buy |
+220
| New | +$10K | ﹤0.01% | 445 |
|
|
2019
Q4 | – | Sell |
-500
| Closed | -$4K | – | 527 |
|
|
2019
Q3 | $4K | Buy |
+500
| New | +$4K | ﹤0.01% | 444 |
|
|
2018
Q4 | – | Sell |
-200
| Closed | -$4K | – | 487 |
|
|
2018
Q3 | $4K | Sell |
200
-150
| -43% | -$3K | ﹤0.01% | 430 |
|
|
2018
Q2 | $6K | Buy |
350
+267
| +322% | +$4.58K | ﹤0.01% | 604 |
|
|
2018
Q1 | $2K | Buy |
+83
| New | +$2K | ﹤0.01% | 711 |
|